Clinical Trial Update: Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial of inhaled AmBisome (liposomal amphotericin B) to prevent Aspergillus colonization in lung transplant recipients has been susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lung Transplant Recipient | Phase 2 | Status: SUSPENDED